Fingerprint
Dive into the research topics of 'Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis
Sameer A. Parikh, Hagop Kantarjian, Aaron Schimmer, William Walsh, Ekatherine Asatiani, Khaled El-Shami, Elliott Winton, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
69
Scopus
citations